Oriola Oyj (LON:0NES)

Market Cap	191.96M
Revenue (ttm)	1.61B
Net Income (ttm)	-23.65M
Shares Out	n/a
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	18.72
Dividend	0.06 (5.14%)
Ex-Dividend Date	Apr 3, 2025

Volume	14,894
Average Volume	12,653
Open	1.178
Previous Close	1.184
Day's Range	1.170 - 1.184
52-Week Range	0.877 - 1.220
Beta	0.59
RSI	65.52
Earnings Date	Oct 30, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR